Theodore James Jr. Washburn - 14 Feb 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Principal Accounting Officer
Signature: /s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Issuer symbol: AGIO
Transactions as of: 14 Feb 2022
Net transactions value: -$19,624
Form type: 4
Filing time: 16 Feb 2022, 16:00:33 UTC
Previous filing: 14 Feb 2022
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+360	+12%	$0.000000	3,413	14 Feb 2022	Direct	F1, F2
transaction	AGIO	Common stock	Tax liability	$3,874	-127	-3.7%	$30.50	3,286	14 Feb 2022	Direct
transaction	AGIO	Common stock	Sale	$15,750	-504	-15%	$31.25	2,782	14 Feb 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Options Exercise	$0	-360	-50%	$0.000000	360	14 Feb 2022	Common stock	360		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2	Includes 34 shares purchased through the Company's employee stock purchase plan.
F3	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4	The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.